Evidence map›Paper›PMID 19252785›Full record

ReviewJournal of neurology2009

Vestibular migraine: a critical review of treatment trials.

Majid Fotuhi, Braeme Glaun, Susan Y Quan, Tzipora Sofare

Abstract readReview
PubMed Publisher
In one paragraph

Review in Journal of neurology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 2 pooled it
3.6field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 2 syntheses or guidelines pooled it, 76 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Flunarizine in the prophylaxis of migrainous vertigo: a randomized controlled trial.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2014
    Trial
  4. Trial
  5. Article
  6. Article
  7. The Relationship Between Vestibular Migraine and Motion Sickness Susceptibility.Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology · 2020
    Article
  8. Review
  9. Distribution of 5-HTFrontiers in neurology · 2016
    Article
  10. Review
  11. Review
  12. Review
  13. Nimodipine in otolaryngology: from past evidence to clinical perspectives.Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale · 2015
    Review
  14. Vestibular Migraine.Noro psikiyatri arsivi · 2013
    Review
  15. Article
  16. Management of vestibular migraine.Therapeutic advances in neurological disorders · 2011
    Article
  17. Article
  18. Article
  19. Prophylactic treatment of vestibular migraine.Brazilian journal of otorhinolaryngology
    Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Majid FotuhiCenter for Balance, Dizziness, and Vertigo, LifeBridge Health Brain & Spine Institute, 5051 Greenspring Avenue, Baltimore, MD 21209, USA. mfotuhi@lifebridgehealth.org
Braeme Glaun
Susan Y Quan
Tzipora Sofare
LifeBridge Health · USJohns Hopkins University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vestibular migraine (VM), also known as migraine-associated vertigo, is a common cause of dizziness in adults. We performed a comprehensive literature search regarding treatment for VM or migraine-associated vertigo during the period of 1990-2008 and used, individually or in combination, the search terms VM, migraine-associated vertigo, migraine-associated dizziness, migrainous vertigo, migraine and vertigo, migraine and disequilibrium, and headache and vertigo. We found nine publications that address treatment strategies for VM. One small randomized clinical trial found some benefit from the use of zolmitriptan for abortive treatment of VM. The other eight observational studies showed marginal improvement with migraine prophylactic medications such as nortriptyline, verapamil, or metoprolol. Until more specific treatment options become available, patients with VM need to be managed with similar prophylactic and abortive strategies as those used for migraine in adults.

Indexed as

Adrenergic beta-AntagonistsAntidepressive Agents, TricyclicCalcium Channel BlockersDizzinessHumansMigraine DisordersRisk Reduction BehaviorSerotonin Receptor AgonistsVertigoVestibular DiseasesAdrenergic beta-AntagonistsAntidepressive Agents, TricyclicCalcium Channel BlockersSerotonin Receptor Agonists

Identifiers

PMID19252785
OpenAlexW2025217563

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.